149 related articles for article (PubMed ID: 15126327)
21. Myristoylation-mediated phase separation of EZH2 compartmentalizes STAT3 to promote lung cancer growth.
Zhang J; Zeng Y; Xing Y; Li X; Zhou L; Hu L; Chin YE; Wu M
Cancer Lett; 2021 Sep; 516():84-98. PubMed ID: 34102285
[TBL] [Abstract][Full Text] [Related]
22. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.
Ueda K; Kawashima H; Ohtani S; Deng WG; Ravoori M; Bankson J; Gao B; Girard L; Minna JD; Roth JA; Kundra V; Ji L
Cancer Res; 2006 Oct; 66(19):9682-90. PubMed ID: 17018626
[TBL] [Abstract][Full Text] [Related]
23. Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells.
Shiraishi T; Misumi S; Takama M; Takahashi I; Shoji S
Biochem Biophys Res Commun; 2001 Apr; 282(5):1201-5. PubMed ID: 11302743
[TBL] [Abstract][Full Text] [Related]
24. TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin.
Xiaobo C; Majidi M; Feng M; Shao R; Wang J; Zhao Y; Baladandayuthapani V; Song J; Fang B; Ji L; Mehran R; Roth JA
Sci Rep; 2016 Nov; 6():35741. PubMed ID: 27845352
[TBL] [Abstract][Full Text] [Related]
25. Roles of Protein N-Myristoylation and Translational Medicine Applications.
Xu M; Xie L; Yu Z; Xie J
Crit Rev Eukaryot Gene Expr; 2015; 25(3):259-68. PubMed ID: 26558949
[TBL] [Abstract][Full Text] [Related]
26. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
[TBL] [Abstract][Full Text] [Related]
27. Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression.
Kim S; Alsaidan OA; Goodwin O; Li Q; Sulejmani E; Han Z; Bai A; Albers T; Beharry Z; Zheng YG; Norris JS; Szulc ZM; Bielawska A; Lebedyeva I; Pegan SD; Cai H
Cancer Res; 2017 Dec; 77(24):6950-6962. PubMed ID: 29038344
[TBL] [Abstract][Full Text] [Related]
28. Role of N-myristoylation in stability and subcellular localization of the CLPABP protein.
Maeda A; Uchida M; Nishikawa S; Nishino T; Konishi H
Biochem Biophys Res Commun; 2018 Jan; 495(1):1249-1256. PubMed ID: 29180010
[TBL] [Abstract][Full Text] [Related]
29. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
[TBL] [Abstract][Full Text] [Related]
30. FUS1 acts as a tumor-suppressor gene by upregulating miR-197 in human glioblastoma.
Xin J; Zhang XK; Xin DY; Li XF; Sun DK; Ma YY; Tian LQ
Oncol Rep; 2015 Aug; 34(2):868-76. PubMed ID: 26081814
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
32. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
33. Frequent absence of tumor suppressor FUS1 protein expression in human bone and soft tissue sarcomas.
Li G; Kawashima H; Ji L; Ogose A; Ariizumi T; Umezu H; Xu Y; Hotta T; Endo N
Anticancer Res; 2011 Jan; 31(1):11-21. PubMed ID: 21273575
[TBL] [Abstract][Full Text] [Related]
34. Post-translational myristoylation: Fat matters in cellular life and death.
Martin DD; Beauchamp E; Berthiaume LG
Biochimie; 2011 Jan; 93(1):18-31. PubMed ID: 21056615
[TBL] [Abstract][Full Text] [Related]
35. Experimental testing of predicted myristoylation targets involved in asymmetric cell division and calcium-dependent signalling.
Benetka W; Mehlmer N; Maurer-Stroh S; Sammer M; Koranda M; Neumüller R; Betschinger J; Knoblich JA; Teige M; Eisenhaber F
Cell Cycle; 2008 Dec; 7(23):3709-19. PubMed ID: 19029837
[TBL] [Abstract][Full Text] [Related]
36. SVMyr: A Web Server Detecting Co- and Post-translational Myristoylation in Proteins.
Madeo G; Savojardo C; Martelli PL; Casadio R
J Mol Biol; 2022 Jun; 434(11):167605. PubMed ID: 35662454
[TBL] [Abstract][Full Text] [Related]
37. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.
Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH
Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875
[TBL] [Abstract][Full Text] [Related]
38. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
39. Analysis and Prediction of Myristoylation Sites Using the mRMR Method, the IFS Method and an Extreme Learning Machine Algorithm.
Wang S; Zhang YH; Huang G; Chen L; Cai YD
Comb Chem High Throughput Screen; 2017; 20(2):96-106. PubMed ID: 28000567
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer.
Picchio MC; Martin ES; Cesari R; Calin GA; Yendamuri S; Kuroki T; Pentimalli F; Sarti M; Yoder K; Kaiser LR; Fishel R; Croce CM
Clin Cancer Res; 2004 Apr; 10(8):2720-4. PubMed ID: 15102676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
